Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase

• Kushol Gupta ,

  Contributed equally to this work with: Kushol Gupta, Vesa Turkki

  Affiliation Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  http://orcid.org/0000-0002-7006-2667

  ⨯
• Vesa Turkki ,

  Contributed equally to this work with: Kushol Gupta, Vesa Turkki

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  http://orcid.org/0000-0001-9626-1966

  ⨯
• Scott Sherrill-Mix,

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Young Hwang,

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Grant Eilers,

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  ⨯
• Louis Taylor,

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  http://orcid.org/0000-0002-6993-5838

  ⨯
• Charlene McDanal,

  Affiliation HIV DPU, Infectious Disease Therapy Area Unit GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Ping Wang,

  Affiliation HIV DPU, Infectious Disease Therapy Area Unit GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• David Temelkoff,

  Affiliation HIV DPU, Infectious Disease Therapy Area Unit GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  ⨯
• Robert T. Nolte,

  Affiliation Protein Cellular and Structural Science, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America

  http://orcid.org/0000-0003-1876-2049

  ⨯
• Emile Velthuisen,

  Affiliation HIV DPU, Infectious Disease Therapy Area Unit GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  http://orcid.org/0000-0001-5781-8805

  ⨯
• Jerry Jeffrey,

  Affiliation HIV DPU, Infectious Disease Therapy Area Unit GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  http://orcid.org/0000-0001-7303-8737

  ⨯
• Gregory D. Van Duyne ,

  * E-mail: vanduyne@mail.med.upenn.edu (GVD); bushman@mail.med.upenn.edu (FDB)

  Affiliation Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  http://orcid.org/0000-0003-0247-1626

  ⨯
• Frederic D. Bushman

  * E-mail: vanduyne@mail.med.upenn.edu (GVD); bushman@mail.med.upenn.edu (FDB)

  Affiliation Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America

  http://orcid.org/0000-0003-4740-4056

  ⨯